Drug resistance mutations in patients infected with HIV-2 living in Spain
Ana Cecilia Treviño(Instituto de Salud Carlos III), José Manuel Ramos(Universitat de Miguel Hernández d'Elx), Jorge del Romero(Hospital Provincial de Conxo), Marta García‐Campello, A. M. Martin, C. Tuset, Alejandro Vallejo(Instituto Ramón y Cajal de Investigación Sanitaria), Domingo Escudero(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Júlia Miró, E. Caballero(Vall d'Hebron Hospital Universitari), Francisco J. Medrano(Instituto de Salud Carlos III), Manuel Rodríguez‐Iglesias, Goitzane Marcaida(Vall d'Hebron Hospital Universitari), Fernando Dronda(Hospital Universitario Ramón y Cajal), A. Hernández-Betancor, T. Tuset, I. Paz, J. Diz, M. Borràs, Matilde Trigo, Patrícia Álvarez, Enrique J. Calderón(deCODE Genetics (Iceland)), José Javier Rodríguez(Hospital de Poniente), Santiago Moreno(Universidad El Bosque), Carmen Rodríguez(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Irma Molina, Emilio Pujol, F. Capote(Hôpital Purpan), Tomàs Pumarola(Universitat Autònoma de Barcelona), M Leal, S. Cortizo(Hospital Clínico Universitario Lozano Blesa)
Cited by 34
Related Papers
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342